Newsfiscal.ai
VolitionRx Limited Signs Letter of Intent with Missionpharma for NETosis Lateral Flow Technology
· Published
Article summary
VolitionRx Limited has executed a non-binding Letter of Intent with Missionpharma A/S to explore the development and distribution of its prototype Lateral Flow Technology for NETosis.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…